259 related articles for article (PubMed ID: 16183529)
1. Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours.
O'Toole D; Ruszniewski P
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):585-94. PubMed ID: 16183529
[TBL] [Abstract][Full Text] [Related]
2. Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors.
Ruszniewski P; O'Toole D
Neuroendocrinology; 2004; 80 Suppl 1():74-8. PubMed ID: 15477722
[TBL] [Abstract][Full Text] [Related]
3. Ablative therapies for liver metastases of digestive endocrine tumours.
O'Toole D; Maire F; Ruszniewski P
Endocr Relat Cancer; 2003 Dec; 10(4):463-8. PubMed ID: 14713259
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for gastro-enteropancreatic endocrine tumours.
O'Toole D; Hentic O; Corcos O; Ruszniewski P
Neuroendocrinology; 2004; 80 Suppl 1():79-84. PubMed ID: 15477723
[TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic disease in patients with neuroendocrine tumors.
Niederhuber JE; Fojo T
Surg Oncol Clin N Am; 2006 Jul; 15(3):511-33, viii. PubMed ID: 16882495
[TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumours.
Dominguez S; Denys A; Menu Y; Ruszniewski P
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S213-5. PubMed ID: 10604133
[TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study.
Maire F; Lombard-Bohas C; O'Toole D; Vullierme MP; Rebours V; Couvelard A; Pelletier AL; Zappa M; Pilleul F; Hentic O; Hammel P; Ruszniewski P
Neuroendocrinology; 2012; 96(4):294-300. PubMed ID: 22507901
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of pancreatic-duodenal endocrine tumors].
O'Toole D; Kianmanesh R; Farges O; Ruszniewski P
Rev Prat; 2002 Sep; 52(14):1546-53. PubMed ID: 12412302
[TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver.
Gaur SK; Friese JL; Sadow CA; Ayyagari R; Binkert CA; Schenker MP; Kulke M; Baum R
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):566-72. PubMed ID: 21431978
[TBL] [Abstract][Full Text] [Related]
10. Stop-flow perfusion with mitomycin-C as locoregional approach in the treatment of large-unresectable liver metastases.
Gadaleta C; Catino A; Mattioli V
In Vivo; 2006; 20(6A):769-71. PubMed ID: 17203765
[TBL] [Abstract][Full Text] [Related]
11. Surgical therapy of liver metastases.
Kuvshinoff B; Fong Y
Semin Oncol; 2007 Jun; 34(3):177-85. PubMed ID: 17560979
[TBL] [Abstract][Full Text] [Related]
12. Endocrine tumours of the gastrointestinal tract. Transplantation in the management of metastatic endocrine tumours.
Pascher A; Klupp J; Neuhaus P
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):637-48. PubMed ID: 16183532
[TBL] [Abstract][Full Text] [Related]
13. Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases.
Norton JA
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):577-83. PubMed ID: 16183528
[TBL] [Abstract][Full Text] [Related]
14. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
[TBL] [Abstract][Full Text] [Related]
15. Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin.
Johanson V; Tisell LE; Olbe L; Wängberg B; Nilsson O; Ahlman H
Br J Cancer; 1999 Jun; 80(8):1259-61. PubMed ID: 10376980
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
[TBL] [Abstract][Full Text] [Related]
17. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
Auernhammer CJ; Jauch KW; Hoffmann JN
Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
[TBL] [Abstract][Full Text] [Related]
18. Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors.
Mostafa EM; Ganguli S; Faintuch S; Mertyna P; Goldberg SN
J Vasc Interv Radiol; 2008 Dec; 19(12):1740-8. PubMed ID: 18951042
[TBL] [Abstract][Full Text] [Related]
19. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
[TBL] [Abstract][Full Text] [Related]
20. The surgical and systemic management of neuroendocrine tumors of the pancreas.
Abood GJ; Go A; Malhotra D; Shoup M
Surg Clin North Am; 2009 Feb; 89(1):249-66, x. PubMed ID: 19186239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
